|
CardioInsight Technologies |
|
|
11000 Cedar Avenue, Suite 100
Cleveland, OH 44106-3052 USA
phone:216-453-5950 x109
fax:
|
|
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
| www.cardioinsight.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Commercializing a revolutionary technology called
Electrocardiographic Mapping (ECM) that non-invasively generates 3D images of the electrical activity of the heart. |
|
| Management |
| Steve Arless CEO; Charu Ramanathan, Co-founder & VP Clinical and Business Development; Harold Wodlinger, VP Product Development, Christina Vacca,VP Quality, Regulatory Affairs & Operations; Kevin Mendelsohn, VP Finance and Corporate Development |
| |
|
|
| |
|
| Keywords |
| cardiology, Electrocardiographic Mapping (ECM), non-invasive, arrhythmias, congestive heart failure, diagnostics |
|
|
|
| Description |
|
CardioInsight Technologies (CIT) is commercializing a revolutionary technology called
Electrocardiographic Mapping (ECM) that non-invasively generates 3D images of the
electrical activity of the heart. The images help physicians more accurately treat certain
heart ailments such as arrhythmias and congestive heart failure. ECM non-invasively
generates real-time, whole heart images of the electrical activity on the surface of the
heart by combining body surface electrical data with 3-D anatomical data obtained
from CT scans. The system is composed of a disposable electrode body surface array
(vest) that captures electrical information from the surface of the heart, and a data
analysis workstation that uses sophisticated, patented software to compute and visualize
3D electroanatomic maps and electrograms from the surface of the whole heart. The
CIT system reconstructs and displays 3D images and other useful measures of cardiac
electrical activity as if the measurements were taken directly from the surface of the
heart. |
|
|
| Status |
| CIT's EC Mapping system is currently being used in five (5) world class EP centers in the US and Europe, including the Cleveland Clinic, University Hospitals of Cleveland, Centre Hopitalaire Universitaire in Bordeaux, France, Loyola University in Chicago, and the University of Pennsylvania Medical Center. The ability of the system to generate accurate images of the heart's electrical activity and its potential to guide therapy in both cardiac arrhythmias and congestive heart failure has been demonstrated in over 250 patient studies sponsored by the Company. CIT expects to launch the EC Mapping system commercially in June 2011. |
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members